Literature DB >> 17611984

Detection of high levels of 2 specific isoforms of 14-3-3 proteins in synovial fluid from patients with joint inflammation.

Ruhangiz T Kilani1, Walter P Maksymowych, Alastair Aitken, Gilles Boire, Yves St-Pierre, Yunyuan Li, Aziz Ghahary.   

Abstract

OBJECTIVE: To investigate whether 14-3-3 proteins were detectable in synovial fluid (SF) of patients with inflamed joints, and if so, what isoform(s); and to examine whether there was a correlation between the levels of these proteins and those of MMP-1 and MMP-3 in the same samples.
METHODS: In general, 2 sets of synovial and serum samples were analyzed. The first set of 17 SF -samples from patients with inflamed joints were analyzed for 14-3-3 eta isoform by Western blot. The second set of 12 matching serum and SF samples were analyzed for 14-3-3 eta, gamma, MMP-1, and MMP-3 by the same procedure. The MMP-1 stimulatory effect of various concentrations of 14-3-3 eta in cultured fibroblasts was then evaluated.
RESULTS: We found that of the seven 14-3-3 isoforms tested (beta, gamma, epsilon, eta, sigma, Theta, and zeta), the levels of only 2 isoforms, eta and gamma, were easily detectable in SF samples from patients with inflammatory joint diseases. The levels of these proteins were significantly higher in inflammatory SF and serum samples relative to controls. The values of these proteins correlated strongly with the levels of MMP-1 and MMP-3, 2 biomarkers for rheumatoid arthritis, detected in sera. Further, the level of 14-3-3 eta was significantly higher in a pool of 12 serum samples from patients with inflammatory joint disease than those from healthy individuals.
CONCLUSION: Detection of only 2 (14-3-3 eta and gamma) out of 7 different isoforms in SF suggests they are specific to the site of inflammation, and that distinguishes them from barely detectable levels of these isoforms found in normal serum. The MMP-1 stimulatory effect of the eta isoform explains its correlation with MMP-1 levels seen in these samples.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611984

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  26 in total

Review 1.  14-3-3 proteins as potential therapeutic targets.

Authors:  Jing Zhao; Cheryl L Meyerkord; Yuhong Du; Fadlo R Khuri; Haian Fu
Journal:  Semin Cell Dev Biol       Date:  2011-10-01       Impact factor: 7.727

2.  14-3-3ζ Overexpression and abnormal β-catenin expression are associated with poor differentiation and progression in stage I non-small cell lung cancer.

Authors:  Dongyu Zang; Xiaoming Li; Lin Zhang
Journal:  Clin Exp Med       Date:  2010-01-29       Impact factor: 3.984

3.  Increased levels of the 14-3-3 η and γ proteins in the synovial fluid of dogs with unilateral cranial cruciate ligament rupture.

Authors:  Kamran Sardari; Claudia Chavez-Muñoz; Ruhangiz T Kilani; Terri Schiller; Aziz Ghahary
Journal:  Can J Vet Res       Date:  2011-10       Impact factor: 1.310

4.  14-3-3 in Thoracic Aortic Aneurysms: Identification of a Novel Autoantigen in Large Vessel Vasculitis.

Authors:  Ritu Chakravarti; Karishma Gupta; Mamuni Swain; Belinda Willard; Jaclyn Scholtz; Lars G Svensson; Eric E Roselli; Gosta Pettersson; Douglas R Johnston; Edward G Soltesz; Michifumi Yamashita; Dennis Stuehr; Thomas M Daly; Gary S Hoffman
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

5.  Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation.

Authors:  Zenggang Li; Jing Zhao; Yuhong Du; Hae Ryoun Park; Shi-Yong Sun; Leon Bernal-Mizrachi; Alastair Aitken; Fadlo R Khuri; Haian Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-27       Impact factor: 11.205

6.  Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis.

Authors:  Fang Wang; Jia-Nan Wang; Xiao-Yan He; Xiao-Guo Suo; Chao Li; Wei-Jian Ni; Yu-Ting Cai; Yuan He; Xin-Yun Fang; Yu-Hang Dong; Tian Xing; Ya-Ru Yang; Feng Zhang; Xiang Zhong; Hong-Mei Zang; Ming-Ming Liu; Jun Li; Xiao-Ming Meng; Juan Jin
Journal:  Acta Pharmacol Sin       Date:  2021-04-08       Impact factor: 6.150

7.  The significance of serum 14-3-3η level in rheumatoid arthritis patients.

Authors:  Dina Anas Abdel Hai Hussin; Reham M Shaat; Shereen Salah Metwally; Manal Awad
Journal:  Clin Rheumatol       Date:  2021-01-05       Impact factor: 2.980

8.  The pro-inflammatory cytokine 14-3-3ε is a ligand of CD13 in cartilage.

Authors:  Meriam Nefla; Laure Sudre; Guillaume Denat; Sabrina Priam; Gwenaëlle Andre-Leroux; Francis Berenbaum; Claire Jacques
Journal:  J Cell Sci       Date:  2015-07-24       Impact factor: 5.285

9.  Serum 14-3-3η protein is associated with clinical and serologic features of Sjögren's syndrome in patients with systemic lupus erythematosus: a cross-sectional analysis.

Authors:  Nevin Hammam; Nada M Gamal; Mona H Elzohri; Amira M Elsonbaty; Ahmed M Rashed; Zeiad H Eldaly; Dalia Tarik; Tamer A Gheita
Journal:  Clin Rheumatol       Date:  2020-03-23       Impact factor: 2.980

10.  Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab.

Authors:  Shintaro Hirata; Anthony Marotta; Yuan Gui; Kentaro Hanami; Yoshiya Tanaka
Journal:  Arthritis Res Ther       Date:  2015-10-09       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.